Pathology Research International of primary and metastatic lung adenocarcinoma among cytologically poorly diﬀerentiated carcinomas,” Cancer Cytopathology, vol. 118, no. 6, pp. 441–449, 2010. [25] J. Fukuoka, T. Dracheva, J. H. Shih et al., “Desmoglein 3 as a prognostic factor in lung cancer,” Human Pathology, vol. 38, no. 2, pp. 276–283, 2007. [26] V. Monica, P. Ceppi, L. Righi et al., “Desmocollin-3: a new marker of squamous diﬀerentiation in undiﬀerentiated large-cell carcinoma of the lung,” Modern Pathology, vol. 22, no. 5, pp. 709–717, 2009. [27] D. Lebanony, H. Benjamin, S. Gilad et al., “Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma,” Journal of Clinical Oncology, vol. 27, no. 12, pp. 2030–2037, 2009. [28] J. A. Bishop, H. Benjamin, H. Cholakh, A. Chajut, D. P. Clark, and W. H. Westra, “Accurate classiﬁcation of non-small cell lung carcinoma using a novel microRNA-based approach,” Clinical Cancer Research, vol. 16, no. 2, pp. 610–619, 2010. [29] V. D. Vescovo, C. Cantaloni, A. Cucino et al., “MiR- 205 expression levels in nonsmall cell lung cancerdo not always distinguish adenocarcinomas from squamous cell carcinomas,” American Journal of Surgical Pathology, vol. 35, no. 2, pp. 268–275, 2011. [30] H. Cheng, X. Xu, D. B. Costa, C. A. Powell, and B. Halmos, “Molecular testing in lung cancer: the time is now,” Current Oncology Reports, vol. 12, no. 5, pp. 335–348, 2010. [31] D. P. Clark, “Seize the opportunity: underutilization of ﬁne- needle aspiration biopsy to inform targeted cancer therapy decisions,” Cancer Cytopathology, vol. 117, no. 5, pp. 289–297, 2009. [32] S. Sanati, D. W. Lu, E. Schmidt, A. Perry, L. P. Dehner, and J. D. Pfeifer, “Cytologic diagnosis of ewing sarcoma/peripheral neuroectodermal tumor with paired prospective molecular genetic analysis,” Cancer, vol. 111, no. 3, pp. 192–199, 2007. [33] N. K. B. Pang, S. Y. Chin, M. E. Nga et al., “Comparative vali- dation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stro- mal tumours,” Cytopathology, vol. 20, no. 5, pp. 297–303, 2009. [34] O. C. J. Schuurbiers, M. G. Looijen-Salamon, M. J. L. Ligtenberg, and H. F. M. Van Der Heijden, “A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound- guided ﬁne needle cytological aspirates,” Journal of Thoracic Oncology, vol. 5, no. 10, pp. 1664–1667, 2010. [35] J. H. Smouse, E. S. Cibas, P. A. Ja¨nne, V. A. Joshi, K. H. Zou, and N. I. Lindeman, “EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer,” Cancer Cytopathology, vol. 117, no. 1, pp. 67–72, 2009. [36] M. E. Arcila, G. R. Oxnard, K. Nafa et al., “Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay,” Clinical Cancer Research, vol. 17, no. 5, pp. 1169–1180, 2011. [37] C. R. Kelsey, L. B. Marks, D. Hollis et al., “Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients,” Cancer, vol. 115, no. 22, pp. 5218–5227, 2009. [38] G. Sica, A. Yoshizawa, C. S. Sima et al., “A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors,” The American Journal of Surgical Pathology, vol. 34, no. 8, pp. 1155–1162, 2010. 7 [39] D. E. Rudomina, O. Lin, and A. L. Moreira, “Cytologic diagnosis of pulmonary adenocarcinoma with micropapillary pattern: does it correlate with the histologic ﬁndings?” Diagnostic Cytopathology, vol. 37, no. 5, pp. 333–339, 2009. [40] C. S. Sigel, D. E. Rudomina, N. Rekhtman, W. D. Travis, K. Geisinger, and A. L. Moreira, “Predicting Pulmonary Adenocarcinoma Outcome Based on a Cytology Grading System,” Cancer Cytopathol, (In press). [41] M. Brevet, M. Arcila, and M. Ladanyi, “Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies speciﬁc to the two major forms of mutant EGFR,” Journal of Molecular Diagnostics, vol. 12, no. 2, pp. 169–176, 2010. [42] J. H. Paik, G. Choe, H. Kim et al., “Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with ﬂuorescence in situ hybridization,” Journal of Thoracic Oncology, vol. 6, no. 3, pp. 466–472, 2011. [43] E. S. Yi, J. M. Boland, J. J. Maleszewski et al., “Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH,” Journal of Thoracic Oncology, vol. 6, no. 3, pp. 459–465, 2011. [44] J. Eckardt, K. E. Olsen, and P. B. Licht, “Endobronchial ultrasound-guided transbronchial needle aspiration of undiagnosed chest tumors,” World Journal of Surgery, vol. 34, no. 8, pp. 1823–1827, 2010. [45] M. A. Friedlander, C. S. Sigel, D. Finley et al., “Endobronchial ultrasound-guided transbronchial needle aspiration cytology—the memorial sloan-kettering cancer center experience,” Cancer Cytopathology, vol. 118, no. 5, pp. 363–364, 2010. [46] K. G. Tournoy, F. De Ryck, L. R. Vanwalleghem et al., “Endo- scopic ultrasound reduces surgical mediastinal staging in lung cancer: a randomized trial,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 5, pp. 531–535, 2008. [47] T. S. Weiser, K. Hyman, J. Yun, V. Litle, C. Chin, and S. J. Swanson, “Electromagnetic navigational bronchoscopy: a surgeon’s perspective,” Annals of Thoracic Surgery, vol. 85, no. 2, pp. S797–S801, 2008. [48] B. Lamprecht, P. Porsch, C. Pirich, and M. Studnicka, “Electromagnetic navigation bronchoscopy in combination with PET-CT and rapid on-site cytopathologic examination for diagnosis of peripheral lung lesions,” Lung, vol. 187, no. 1, pp. 55–59, 2009. [49] G. Schreiber and D. C. McCrory, “Performance characteristics of diﬀerent modalities for diagnosis of suspected lung cancer: summary of published evidence,” Chest, vol. 123, no. 1, pp. 115S–128S, 2003. [50] L. Santambrogio, M. Nosotti, N. Bellaviti, G. Pavoni, F. Radice, and V. Caputo, “CT-guided ﬁne-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation,” Chest, vol. 112, no. 2, pp. 423–425, 1997.